The Usefulness of Serum Biomarkers in the Early Stages of Diabetic Retinopathy: Results of the EUROCONDOR Clinical Trial

The main aim of this study was to evaluate the ability of serum biomarkers to predict the worsening of retinal neurodysfunction in subjects with type 2 diabetes. For this purpose, we measured selected molecules (N-epsilon-carboxy methyl lysine (CML), laminin P1 (Lam-P1), and asymmetric dimethylargin...

Descripción completa

Detalles Bibliográficos
Autores principales: Hernández, Cristina, Porta, Massimo, Bandello, Francesco, Grauslund, Jakob, Harding, Simon P., Aldington, Stephen J., Egan, Catherine, Frydkjaer-Olsen, Ulrik, García-Arumí, José, Gibson, Jonathan, Lang, Gabriele E., Lattanzio, Rosangela, Massin, Pascale, Midena, Edoardo, Ponsati, Berta, Ribeiro, Luísa, Scanlon, Peter, Cunha-Vaz, José, Simó, Rafael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7231127/
https://www.ncbi.nlm.nih.gov/pubmed/32344735
http://dx.doi.org/10.3390/jcm9041233

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7231127/
https://www.ncbi.nlm.nih.gov/pubmed/32344735
http://dx.doi.org/10.3390/jcm9041233

Ejemplares similares